2024-11-07T08:31:31-06:00 2023-12-31 042571780 AAFCPAS INC 50 WASHINGTON STREET WESTBOROUGH MA 01581 990PF 2023-01-01 043507847 CHARLES H HOOD FOUNDATION CHAR 6172792230 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 NEIL SMILEY PRESIDENT AND TREASURER 6172792230 2024-11-06 1 1 JOYCE RIPIANZI CPA P00548581 5083669100 2024-11-06 2023 2024-10-15 13:58:12Z X 72008150 X 281358 1391087 1391087 1660066 6170716 1660066 6033 6600 0 3339111 3051153 6033 0 0 0 6096 0 6096 30089 0 30089 101646 88323 13323 4142 0 0 56398 35359 1039 15803 0 15803 332834 0 332834 547008 123682 399184 2150250 2150250 2697258 123682 2549434 641853 2927471 6033 383193 204648 204648 34837751 35440583 35440583 13292160 13614650 13614650 14795058 18742212 18742212 3369961 4006057 4006057 66678123 72008150 72008150 0 0 X 59300755 59300755 0 0 7377368 12707395 66678123 72008150 66678123 72008150 66678123 641853 5298086 72618062 609912 72008150 PUBLICLY TRADED SECURITIES 6170716 4510650 1660066 1660066 1660066 40692 0 40692 0 40692 42027 0 0 0 42027 0 1335 1335 0 0 0 0 0 0 0 0 0 1 1 0 1 1 MA 1 0 0 1 0 1 HTTPS://HRIA.ORG/TMF/HOOD/ AAFCPAS INC 5083669100 50 WASHINGTON STREET WESTBOROUGH MA 01581 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 NEIL SMILEY 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 PRESIDENT AND TREASURER 1.00 0 0 0 JOHN O PARKER JR 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 VICE PRESIDENT AND CLERK 1.00 0 0 0 ROBERT C BOUTWELL 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 TRUSTEE 1.00 0 0 0 BARBARA BULA 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 TRUSTEE 1.00 0 0 0 BRENDON BULA 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 TRUSTEE 1.00 0 0 0 ELIZABETH HOOD 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 TRUSTEE 1.00 0 0 0 CLAY SMILEY 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 TRUSTEE 1.00 0 0 0 NONE 0 HEALTH RESOURCES IN ACTION 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 ADMINISTRATIVE FEES 256489 PRIME BUCHHOLZ 273 CORPORATE DRIVE SUITE 250 PORTSMOUTH NH 03801 INVESTMENT ADVISORY SERVICES 75000 0 MULBERRY BIOTHERAPEUTICS INC. - WELLESLEY, MACONVERTIBLE PROMISSORY NOTE 250000 PLAKOUS THERAPEUTICS - WINSTOM-SALEM, NCCONVERTIBLE PROMISSORY NOTE 250000 425000 925000 53138962 401650 13979158 67519770 0 0 67519770 1012797 66506973 3325349 3325349 40692 40692 3284657 156033 3440690 0 3440690 2549434 925000 3474434 3440690 3301908 0 0 3474434 3301908 0 0 172526 0 0 0 0 0 0 0 0 3268164 0 0 0 CHARLENE MANCUSI DIRECTOR HRIA 2 BOYLSTON STREET 4TH FLOOR BOSTON MA 02116 6176959439 CMANCUSI@HRIA.ORG APPLICATION FORMS AVAILABLE AT WWW.TMFGRANTS.ORG/HOOD ANNUALLY MARCH AND OCTOBER RESTRICTED TO PEDIATRIC RESEARCH FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH 11400 ROCKVILLE PIKE SUITE 600 NORTH BETHESDA MD 20852 PC SPECIAL GRANT SUPPORT FOR THE PEDIATRIC MEDICAL DEVICE PUBLIC PRIVATE PARTNERSHIP (DESIGN PHASE) 15000 BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVENUE BOSTON MA 02215 PC SPECIAL GRANT SUPPORT FOR THE ENDOWED CHAIR FOR DR. STEVEN FREEDMAN, IN HONOR OF JUDY HOOD 100000 HARVARD MEDICAL SCHOOL PO BOX 415649 BOSTON MA 02241 PC CHARLES AWARD IN PEDIATRIC HEALTH [CHARLES H. HOOD ALUMNI RECOGNITION FOR LEADERSHIP, EXCELLENCE AND SERVICE] - DETECTING PEDIATRIC GROWTH DISORDERS USING AI 100000 TRUSTEES OF DARTMOUTH COLLEGE OFFICE OF SPONSORED PROJECTS 11 ROPE FERRY ROAD HANOVER NH 03755 PC MAJOR GRANT - DECREASING HARMS AND IMPROVING CHILD HEALTH: AN INTERVENTION TO REDUCE INAPPROPRIATE USE OF ANTIPSYCHOTICS AND POLYPHARMACY 70250 UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL C/O BANK OF AMERICA 222 BROADWAY ST NEW YORK NY 10038 PC CHILD HEALTH RESEARCH AWARD - THE ROLE OF MARCO IN PEDIATRIC CANCER 82500 MASSACHUSETTS INSTITUTE OF TECHNOLOGY C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - THE ROLE OF AIRWAY NEURONS IN CHILDHOOD ASTHMA 82500 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - DEVELOPING A BROADLY APPLICABLE THERAPEUTIC STRATEGY TO REVERSE SYMPTOMS OF NEURODEVELOPMENTAL DISORDERS 82500 YALE SCHOOL OF MEDICINE PO BOX 208239 NEW HAVEN CT 06520 PC CHILD HEALTH RESEARCH AWARD - NEURAL MARKERS OF CHRONIC, PERSISTENT PEDIATRIC IRRITABILITY 82500 BRIGHAM AND WOMEN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - SPATIAL MAPPING OF MALIGNANT SUBPOPULATIONS ENABLING NEURON-GLIOMA CIRCUIT INTERACTIONS IN DIPG 82500 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - DISSECTING IMMUNE-STROMAL INTERACTIONS TO DISCOVER NOVEL STRATEGY TO MODULATE INFLAMMATION 82500 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - THE ROLE AND MECHANISM OF MAKORIN RING FINGER PROTEIN 3 IN CHILDREN WITH DELAYED PUBERTY 40000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 1295 BOYLSTON STREET 4TH FL BOSTON MA 02215 PC CHILD HEALTH RESEARCH AWARD - MACHINE-LEARNING PREDICTION MODEL FOR PERSONALIZED URINARY TRACT INFECTION CARE IN CHILDREN 40000 BROWN UNIVERSITY CASHIER OFFICE BOX 1997 69 BROWN STREET 2ND FLOOR PROVIDENCE RI 02912 PC CHILD HEALTH RESEARCH AWARD - DEVELOPMENT OF A HIGH EFFICACY NON-CAPSID NOROVIRUS VACCINE 40000 HARVARD MEDICAL SCHOOL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - DECIPHERING MECHANISMS LINKING CHILDHOOD VIRAL INFECTION AND ASTHMA DEVELOPMENT 40000 WORCESTER POLYTECHNIC INSTITUTE C/O TD BANK 370 MAIN ST WORCESTER MA 01608 PC CHILD HEALTH RESEARCH AWARD - ROLE OF HETEROTRIMERIC G PROTEINS IN CILIA ASSEMBLY AND PATHOGENESIS OF NEURODEVELOPMENTAL DISORDERS 40000 YALE UNIVERSITY C/O BANK OF AMERICA MERRILL LYNCH100 WEST 33RD STREET NEW YORK NY 10001 PC CHILD HEALTH RESEARCH AWARD - DIAGNOSIS OF PEDIATRIC MALIGNANCIES USING DEVELOPMENTAL MAPPING AND MACHINE LEARNING 40000 YALE UNIVERSITY C/O BANK OF AMERICA MERRILL LYNCH100 WEST 33RD STREET NEW YORK NY 10001 PC CHILD HEALTH RESEARCH AWARD - SUPPORTING REFUGEE MENTAL HEALTH THROUGH TRANSLATION OF EVALUATIVE INSTRUMENTS AND THROUGH A PREVENTIVE MENTAL HEALTH INTERVENTION 100000 MASSACHUSETTS GENERAL HOSPITAL BANK OF AMERICA NA PO BOX 414876 BOSTON MA 02241 PC CHILD HEALTH RESEARCH AWARD - TACKLING PULMONARY HYPOPLASIA WITH GENETIC, EPIGENETIC AND STEM CELL APPROACHES. 100000 BOSTON COLLEGE 140 COMMONWEALTH AVE 129 LAKE ST 440 CHESTNUT HILL MA 02467 PC CHILD HEALTH RESEARCH AWARD - IMPROVING CHILDHOOD TUBERCULOSIS TREATMENT OUTCOMES AND POST-TB LUNG FUNCTIONING AND QUALITY OF LIFE IN RURAL SOUTH AFRICA 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - IDENTIFYING EEG-BASED BIOMARKERS OF LANGUAGE GROWTH IN PRESCHOOL-AGED CHILDREN WITH DOWN SYNDROME 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - CHARACTERIZING THE ROLE OF TWO SUBCORTICAL NUCLEI IN PREFRONTAL REGULATION OF ATTENTION 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - POSTNATAL EXPOSURE TO HYPEROXIA CAUSES MALADAPTATION OF THE PREMATURE INTESTINE 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - ROLE OF XENOBIOTIC PATHWAYS TO MODULATE INTESTINAL EPITHELIAL METABOLISM, AS POSSIBLE TARGETS FOR OBESITY AND DIABETES 100000 BRIGHAM AND WOMEN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - THE ROLE OF MESENCHYMAL STEM CELLS TO ENHANCE IMMUNE FUNCTION IN A MODEL OF NEONATAL INFECTION 100000 DARTMOUTH-HITCHCOCK CLINIC RESEARCH OPERATIONS 1 MEDICAL CENTER DRIVE LEBANON NH 03756 PC CHILD HEALTH RESEARCH AWARD - EVALUATING MECHANISMS OF ENVIRONMENTAL CHEMICAL EXPOSURE WITH DEVELOPING ZEBRAFISH URINARY SYSTEM 130000 MASSACHUSETTS EYE AND EAR INFIRMARY C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - ADVANCING THE RETINOIC ACID SIGNALING ACTIVATOR AS A NOVEL THERAPEUTIC IN MOUSE MODELS OF RETINAL DEGENERATION 100000 MASSACHUSETTS GENERAL HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - DECIPHERING THE MECHANISM UNDERLYING SHORT- AND LONG-TERM AIRWAY HYPERRESPONSIVENESS FOLLOWING EARLY-LIFE RSV INFECTION 100000 2150250 YALE UNIVERSITY C/O BANK OF AMERICA MERRILL LYNCH100 WEST 33RD STREET NEW YORK NY 10001 PC CHILD HEALTH RESEARCH AWARD - SUPPORTING REFUGEE MENTAL HEALTH THROUGH TRANSLATION OF EVALUATIVE INSTRUMENTS AND THROUGH A PREVENTIVE MENTAL HEALTH INTERVENTION 100000 MASSACHUSETTS GENERAL HOSPITAL BANK OF AMERICA NA PO BOX 414876 BOSTON MA 02241 PC CHILD HEALTH RESEARCH AWARD - TACKLING PULMONARY HYPOPLASIA WITH GENETIC, EPIGENETIC AND STEM CELL APPROACHES. 100000 BOSTON COLLEGE 140 COMMONWEALTH AVE 129 LAKE ST 440 CHESTNUT HILL MA 02467 PC CHILD HEALTH RESEARCH AWARD - IMPROVING CHILDHOOD TUBERCULOSIS TREATMENT OUTCOMES AND POST-TB LUNG FUNCTIONING AND QUALITY OF LIFE IN RURAL SOUTH AFRICA 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - IDENTIFYING EEG-BASED BIOMARKERS OF LANGUAGE GROWTH IN PRESCHOOL-AGED CHILDREN WITH DOWN SYNDROME 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - CHARACTERIZING THE ROLE OF TWO SUBCORTICAL NUCLEI IN PREFRONTAL REGULATION OF ATTENTION 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - POSTNATAL EXPOSURE TO HYPEROXIA CAUSES MALADAPTATION OF THE PREMATURE INTESTINE 100000 BOSTON CHILDREN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - ROLE OF XENOBIOTIC PATHWAYS TO MODULATE INTESTINAL EPITHELIAL METABOLISM, AS POSSIBLE TARGETS FOR OBESITY AND DIABETES 100000 BRIGHAM AND WOMEN'S HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - THE ROLE OF MESENCHYMAL STEM CELLS TO ENHANCE IMMUNE FUNCTION IN A MODEL OF NEONATAL INFECTION 100000 DARTMOUTH-HITCHCOCK CLINIC RESEARCH OPERATIONS 1 MEDICAL CENTER DRIVE LEBANON NH 03756 PC CHILD HEALTH RESEARCH AWARD - EVALUATING MECHANISMS OF ENVIRONMENTAL CHEMICAL EXPOSURE WITH DEVELOPING ZEBRAFISH URINARY SYSTEM 70000 MASSACHUSETTS EYE AND EAR INFIRMARY C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - ADVANCING THE RETINOIC ACID SIGNALING ACTIVATOR AS A NOVEL THERAPEUTIC IN MOUSE MODELS OF RETINAL DEGENERATION 100000 MASSACHUSETTS GENERAL HOSPITAL C/O BANK OF AMERICA 100 FEDERAL STREET BOSTON MA 02110 PC CHILD HEALTH RESEARCH AWARD - DECIPHERING THE MECHANISM UNDERLYING SHORT- AND LONG-TERM AIRWAY HYPERRESPONSIVENESS FOLLOWING EARLY-LIFE RSV INFECTION 100000 1070000 14 1391087 18 1660066 RETURNED GRANT FUNDS 6033 OTHER INVESTMENT INCOME 567 0 3051153 6600 3057753 11A EXCESS FUNDS RETURNED FROM GRANTS PREVIOUSLY PAID OUT. 11B SETTLEMENT PROCEEDS ON INVESTMENTS 0 0 0 0 0 0 0 0 0 0 X X 1 ESTATE OF JUDITH HOOD BANK OF AMERICA 1025 MAIN ST WALTHAM MA 02451 281358 X ACCOUNTING & TAX PREPARATION FEES 30089 0 30089 NURTURE GENOMICS - CAMBRIDGE, MA SIMPLE AGREEMENT FOR FUTURE EQUITY 250000 ARGUS COGNITIVE, INC. - LEBANON, NH SIMPLE AGREEMENT FOR FUTURE EQUITY 25000 SMOLTAP, INC. - PROVIDENCE, RI SERIES SEED PREFERRED STOCK INVESTMENT 100000 PRAPELA, LLC - BIDDEFORD, ME CONVERTIBLE PROMISSORY NOTE 50000 149 MEDICAL INC 1173 MAIN STREET BOLTON MA 01740 2020-04-17 150000 TO SUPPORT THE PRE-COMMERCIALIZATION DEVELOPMENT OF A MONITOR THAT MEASURES REAL-TIME BRAIN HEMODYNAMICS AND METABOLISM IN PRETERM NEWBORNS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. 150000 NONE, SEE BELOW PRI REPORT - 8/16/2023 2022-06-10 149 MEDICAL DISSOLVED IN 2023. PRIOR TO THIS, THE TRUSTEES MET WITH 149 MEDICAL, INC. ON A REGULAR BASIS, ATTENDED BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. ALDATU BIOSCIENCES INC C/O ARSENAL LAB SPACE 201 DEXTER AVE WATERTOWN MA 02472 2016-02-23 100000 TO SUPPORT THE USE AND DEVELOPMENT OF A SIMPLE, RAPID, THERMOSTABLE KIT THAT IDENTIFIES CLINICALLY ACTIONABLE HIV MUTATIONS FOUND IN PATIENTS FAILING A FIRST-LINE DRUG REGIMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. 100000 NONE, SEE BELOW PRI REPORTS - 5/26/2023, 6/12/2023, 12/12/2023, 6/12/2024 2017-12-15 THE TRUSTEES MEET WITH ALDATU BIOSCIENCES, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. ANIDA PHARMA INC 155 BROOKLINE STREET SUITE 005 CAMBRIDGE MA 02139 2020-12-21 250000 TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A PREVENTATIVE TREATMENT FOR RETINOPATHY OF PREMATURITY, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. 250000 NONE, SEE BELOW PRI REPORTS - 7/21/2023, 8/23/2023, 6/24/2024 2023-07-21 THE TRUSTEES MEET WITH ANIDA PHARMA, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY ARGUS COGNITIVE INC DARTMOUTH REGIONAL TECHNICAL CENTER 16 CAVENDISH LEBANON NH 03766 2021-05-10 250000 TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT. 250000 NONE, SEE BELOW PRI REPORTS -2/22/2023,8/23/2023,9/7/2023,3/5/2024,5/18/2024,6/6/2024,7/3/20 2023-08-23 THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY ARGUS COGNITIVE INC DARTMOUTH REGIONAL TECHNICAL CENTER 16 CAVENDISH LEBANON NH 03766 2023-07-10 25000 TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT. 25000 NONE, SEE BELOW PRI REPORTS -2/22/2023,8/23/2023,9/7/2023,3/5/2024,5/18/2024,6/6/2024,7/3/20 2024-09-13 THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY BIOROSA TECHNOLOGIES INC 63 BAKER STREET BELMONT MA 02478 2020-07-15 150000 TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. 150000 NONE, SEE BELOW PRI REPORTS - 8/14/2023, 10/30/2023, 1/8/2024, 9/24/2024 2021-07-16 THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY BIOROSA TECHNOLOGIES INC 63 BAKER STREET BELMONT MA 02478 2022-11-15 100000 TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. 100000 NONE, SEE BELOW PRI REPORTS - 8/14/2023, 10/30/2023, 1/8/2024, 9/24/2024 2023-08-14 THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY BREEGI SCIENTIFIC INC 120 BEDFORD ROAD WOBURN MA 01801 2017-06-26 250000 THE FUNDS WILL BE USED TO CONDUCT A THOROUGH CLINICAL ASSESSMENT OF BSI'S NOVEL NEONATAL INTENSIVE CARE INCUBATOR "(NICI)" IN HONDURAS AND ZAMBIA AND TO AID THE COMMERCIALIZATION EFFORTS OF THIS LIFE-SAVING MEDICAL DEVICE, THEREBY LESSENING THE BURDEN OF THE GOVERNMENT AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. 250000 NONE, SEE BELOW PRI REPORTS - 1/5/2023, 8/24/2023, 6/3/2024, 10/1/2024 2021-08-02 THE TRUSTEES MEET WITH BREEGI SCIENTIFIC, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY DECK THERAPEUTICS INC 8 HARVARD LANE HASTINGS ON HUDSON NY 10706 2022-10-12 200000 TO SUPPORT THE DEVELOPMENT OF SEMI-SYNTHETIC OMEGA-3 COMPOUNDS THAT BLOCK MULTIPLE CELL-DEATH PATHWAYS INDUCED BY HYPOXIC-ISCHEMIC INJURY IN NEONATES. 200000 NONE, SEE BELOW PRI REPORTS - 3/1/2023, 6/20/2023, 7/24/2023, 10/19/2023, 5/2/2023 2023-05-02 THE TRUSTEES MEET WITH DECK THERAPEUTICS, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY INKSPACE IMAGING INC 5635 W LAS POSITAS BLVD STE 403/404 PLEASANTON CA 94588 2022-10-20 250000 TO SUPPORT THE DEVELOPMENT OF FLEXIBLE, LIGHTWEIGHT, LOW COST MRI COILS DESIGNED SPECIFICALLY FOR PEDIATRIC PATIENTS, WHILE ALSO IMPROVING IMAGE RESOLUTION AND REDUCING MRI FAILURE RATES. 250000 NONE, SEE BELOW PRI REPORTS - 6/5/2023, 8/12/2024 2024-08-12 THE TRUSTEES MEET WITH INKSPACE IMAGING, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY MESENTECH INC 2222 HEALTH SCIENCES RD VANCOUVER BRITISH COLUMBIA CA V6T2B9 2020-11-02 250000 TO SUPPORT THE ADVANCEMENT OF SCIENCE AND PROMOTION OF HEALTH THROUGH THE PRECLINICAL RESEARCH OF ANABOLIC BONE THERAPEUTICS THAT CAN INCREASE BONE MASS TO STRENGTHEN THE SKELETON AND THE DEVELOPMENT OF A DRUG DELIVERY SYSTEM TO BE INITIALLY APPLIED TO TWO PEDIATRIC RARE DISEASES: OSTEOGENESIS IMPERFECTA AND DUCHENNE MUSCULAR DYSTROPHY. 250000 NONE, SEE BELOW PRI REPORTS - 1/27/2023, 7/3/2023, 9/12/2023, 10/2023, 6/4/2024, 6/5/2024 2022-08-26 THE TRUSTEES MEET WITH MESENTECH, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY MULBERRY BIOTHERAPEUTICS INC 40 WALNUT STREET SUITE 301 WELLESLEY MA 02481 2023-12-26 250000 TO SUPPORT PRECLINICAL WORK RELATING TO THE DEVELOPMENT OF A BACTERIA-MEDIATED THERAPY FOR NEUROFIBROMATOSIS TYPE 2. 0 NONE, SEE BELOW PRI REPORT - 6/11/2024 2024-06-11 THE TRUSTEES MEET WITH MULBERRY BIOTHERAPEUTICS INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY NICOLETTE INC 100 W BROADWAY SUITE 3000 LONG BEACH CA 90802 2021-12-23 200000 TO DEVELOP AND TEST A TABLET-BASED APPLICATION THAT TRANSLATES DATA PULLED FROM A BABY'S ELECTRONIC MEDICAL RECORD INTO EASILY UNDERSTOOD, SIMPLE SENTENCES COMPLEMENTED BY VISUAL AIDS, SUCH AS GRAPHS AND CHARTS, FOR THE BENEFIT OF THE PUBLIC, INCLUDING PARENTS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS. 200000 NONE, SEE BELOW PRI REPORT - 7/26/2023, 4/10/2024, 6/17/2024 2024-06-17 THE TRUSTEES MEET WITH NICOLETTE, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY NONINVASIX INC 1700 THE STRAND SUITE 1200 GALVESTON TX 77555 2017-07-27 7000 TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. 7000 NONE, SEE BELOW PRI REPORTS - 1/27/2023, 4/27/2023, 5/25/2023, 8/3/2023, 11/08/2023, 5/31/20 2017-12-15 THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY NONINVASIX INC 1700 THE STRAND SUITE 1200 GALVESTON TX 77555 2015-12-30 150000 TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. 150000 NONE, SEE BELOW PRI REPORTS - 1/27/2023, 4/27/2023, 5/25/2023, 8/3/2023, 11/08/2023, 5/31/20 2017-12-15 THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY NONINVASIXINC 1700 THE STRAND SUITE 1200 GALVESTON TX 77555 2016-07-27 150000 TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT. 150000 NONE, SEE BELOW PRI REPORTS - 1/27/2023, 4/27/2023, 5/25/2023, 8/3/2023, 11/08/2023, 5/31/20 2017-12-15 THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY NOVONATE INC 395 OYSTER POINT BLVD SUITE 501 SOUTH SAN FRANCISCO CA 94080 2022-08-03 150000 TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO BENEFIT THE PUBLIC BY DEVELOPING MEDICAL DEVICES FOR PATIENTS IN THE NEONATAL INTENSIVE CARE UNIT. 150000 NONE, SEE BELOW PRI REPORTS - 7/25/2023, 7/27/2023 2023-07-27 NOVONATE WAS ACQUIRED IN 2023 AND THE $150,000 WAS REPAID TO THE FOUNDATION. PRIOR TO THIS, THE TRUSTEES MET WITH NOVONATE, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEWED THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY NURTURE GENOMICS CAMBRIDGE INNOVATION CENTER ONE BROADWAY KENDALL SQUARE CAMBRIDGE MA 02142 2023-12-26 250000 TO SUPPORT THE PRE-COMMERCIAL AND PILOT DEVELOPMENT OF A SCREENING AND TELEHEALTH PLATFORM TO PROVIDE GENETIC INSIGHTS THAT HELP PARENTS AND THEIR MEDICAL PROVIDERS BETTER UNDERSTAND RISKS FROM CHILDBIRTH INTO ADOLESCENCE. 11974 NONE, SEE BELOW PRI REPORT - 6/23/2024 2024-06-23 THE TRUSTEES MEET WITH NURTURE GENOMICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY PLAKOUS THERAPEUTICS 755 HIGHLAND OAKS DR SUITE 103 WINSTONSALEM NC 27103 2023-07-03 250000 TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A BIOLOGIC TO TREAT BABIES DIAGNOSED OR AT RISK OF DEVELOPING NECROTIZING ENTEROCOLITIS (NEC). 250000 NONE, SEE BELOW PRI REPORTS - 8/10/2023, 2/2/2024, 6/6/2024 2024-02-02 THE TRUSTEES MEET WITH PLAKOUS THERAPEUTICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY PRAPELA LLC 2 MAIN STREET BIDDEFORD ME 04005 2018-07-02 250000 TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. 250000 NONE, SEE BELOW PRI REPORTS - 3/1/2023, 6/22/2023, 7/10/2023, 9/1/2023, 11/1/2023, 6/17/2024 2020-09-10 THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. PRAPELA LLC 2 MAIN STREET BIDDEFORD ME 04005 2023-12-20 50000 TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. 50000 NONE, SEE BELOW PRI REPORTS - 3/1/2023, 6/22/2023, 7/10/2023, 9/1/2023, 11/1/2023, 6/17/2024 2024-09-24 THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. SMOLTAP INC 150 CHESTNUT STREET SUITE C PROVIDENCE RI 02903 2022-07-25 99997 TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD. 99997 NONE, SEE BELOW PRI REPORTS - 2/15/2023, 5/30/2023, 12/22/2023, 5/30/2024, 9/3/2024 2023-05-30 THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY SMOLTAP INC 150 CHESTNUT STREET SUITE C PROVIDENCE RI 02903 2023-09-11 100000 TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD. 100000 NONE, SEE BELOW PRI REPORTS - 2/15/2023, 5/30/2023, 12/22/2023, 5/30/2024, 9/3/2024 2024-05-30 THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY STINGRAY THERAPEUTICS 2450 HOLCOMBE BLVD SUITE X HOUSTON TX 77021 2019-04-08 250000 FUNDS WILL BE USED FOR PRECLINICAL WORK FOCUSED ON PEDIATRIC BRAIN CANCERS, INCLUDING WORK TO DEVELOP PRECLINICAL MODELS AND TO TEST COMPOUNDS AGAINST MEDULLOBLASTOMA, AN ULTRA-RARE PEDIATRIC BRAIN CANCER, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE. 250000 NONE, SEE BELOW PRI REPORTS - 3/2/2023, 5/25/2023, 6/29/2023, 3/6/2024, 4/11/2024, 6/12/2024 2021-05-18 THE TRUSTEES MEET WITH STINGRAY THERAPEUTICS MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. THINKMD INC 166 MAIN STREET BURLINGTON VT 05401 2018-05-17 150000 FOR DEVELOPING INTEGRATED CLINICAL ASSESSMENT AND DATA ANALYTICS PLATFORMS AND OTHER DERIVATIVE PRODUCTS THAT TRANSFORM POINT-OF-CARE MEDICINE BY PUTTING VALIDATED CLINICAL ASSESSMENT CAPABILITY AND INCREASED HEALTHCARE KNOWLEDGE INTO THE HANDS OF CLINICALLY UNTRAINED HEALTHCARE PROFESSIONALS AND FAMILIES THEREBY LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED. 150000 NONE, SEE BELOW PRI REPORTS - 2/20/2023, 5/16/2023, 6/2/2023, 7/5/2023, 9/28/2023, 11/1/2023 2019-02-11 THE TRUSTEES MEET WITH THINKMD, INC. MANAGEMENT ON A REGULAR BASIS, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY. FIXED INCOME 13614650 13614650 DOMESTIC EQUITIES 25644572 25644572 FOREIGN SECURITIES 9796011 9796011 REAL ESTATE FMV 4763054 4763054 ALTERNATIVE INVESTMENTS FMV 13979158 13979158 LEGAL EXPENSES 6096 0 6096 PROGRAM RELATED INVESTMENTS 3369961 4006057 4006057 LOSS ON ALTERNATIVE INVESTMENTS 609912 MISCELLANEOUS EXPENSES 5795 0 5795 HRIA ADMINISTRATIVE COSTS 256489 0 256489 PROGRAM RELATED INVESTMENT ADMINISTRATIVE COSTS 24633 0 24633 MARKETING 19386 0 19386 HONORARIA 18650 0 18650 EVENT EXPENSE 7881 0 7881 RETURNED GRANT FUNDS 6033 6033 OTHER INVESTMENT INCOME 567 567 UNREALIZED GAIN 5298086 INVESTMENT FEES - US TRUST 26646 13323 13323 INVESTMENT CONSULTING 75000 75000 0 FEDERAL EXCISE TAXES FOR 2023 20000 0 0 MA FORM PC FILING FEE 1039 0 1039 FOREIGN TAXES 35359 35359 0